Welcome to the e-CCO Library!

P301: Effects of telemonitoring on safety and health care costs with a web platform (TECCU) in complex IBD patients: A randomised controlled trial
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Aguas1,2,3, J. Del Hoyo1*, R. Faubel4,5, D. Muñoz1, D. Domínguez6, G. Bastida1,2, B. Navarro1, G. Cordon1, A. Barrios1, B. Valdivieso3,7, M. Correcher8, P. Nos1,2,3

Created: Thursday, 21 February 2019, 9:14 AM
P301: Gender influencing attitudes to inflammatory bowel disease: a questionnaire investigating the effect of IBD on body-image, sexual function, and family planning
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Boland*, M. Forry, N. Godwin, E. Tatro, F. E. Murray, G. C. Harewood, S. Patchett, A. O Toole

Created: Friday, 22 February 2019, 9:49 AM
P301: Non-familial small bowel carcinomas in Crohn's disease: clinico-pathological, molecular and prognostic features
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Di Sabatino A.*1, Vanoli A.2, Furlan D.3, Giuffrida P.1, Klersy C.4, Grillo F.5, Fiocca R.5, Mescoli C.6, Rugge M.6, Nesi G.7, Fociani P.8, Sampietro G.9, Ardizzone S.10, Luinetti O.2, Calabrò A.11, Tonelli F.7, Volta U.12, Santini D.13, Caio G.12, Elli L.14, Ferrero S.15, Latella G.16, Ciardi A.17, Solina G.18, Rizzo A.18, Ciacci C.19, D'Armiento F.P.20, Salemme M.21, Villanacci V.21, Cannizzaro R.22, Canzonieri V.23, Reggiani Bonetti L.24, Biancone L.25, Monteleone G.25, Orlandi A.25, Santeusanio G.26, Macciomei M.C.26, D'Incà R.6, Perfetti V.27, Sandri G.28, Silano M.29, Florena A.M.30, Giannone A.G.30, Papi C.31, Coppola L.31, Usai P.32, Maccioni A.33, Astegiano M.34, Migliora P.35, Manca R.36, Martino M.37, Trapani D.3, Cerutti R.3, Alberizzi P.36, Riboni R.36, Sessa F.3, Paulli M.36, Solcia E.2, Corazza G.R.1

Created: Wednesday, 20 February 2019, 10:36 AM
P301: Outcomes following colectomy for patients with Ulcerative Colitis, ten years of data from a tertiary referral centre
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gallagher, A.(1)*;Sheridan, J.(1);Doherty, G.(1);Mulcahy, H.(1);Cullen, G.(1);
Created: Friday, 14 July 2023, 11:05 AM
P301: Relapse rates after withdrawal of thiopurines in patients with Inflammatory Bowel Disease.
Year: 2022
Source: ECCO'22
Authors: Ranjan, M.K.(1);Vuyyuru, S.K.(1);Kante, B.(1);Kumar, P.(1);Mundhra, S.K.(1);Golla, R.(1);Sharma, R.(2);Sahni, P.(3);Das, P.(4);Makharia, G.(1);Kedia, S.(1);Ahuja, V.(1);
Created: Friday, 11 February 2022, 3:52 PM
P301: Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn’s disease: results up to Week 48 of the STARDUST trial
Year: 2021
Source: ECCO'21 Virtual
Authors: Danese, S.(1);Vermeire, S.(2);D'Haens, G.(3);Panés, J.(4);Dignass, A.(5);Magro, F.(6,7);Nazar, M.(8);Le Bars, M.(9);Lahaye, M.(10);Ni, L.(11);Bravatà, I.(12);Gaya, D.R.(13);Peyrin-Biroulet, L.(14);
Created: Wednesday, 2 June 2021, 4:12 PM
P302 Diagnostic accuracy of a serum-based biomarker panel for endoscopic activity in ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. HOLMER, B. Boland, S. Singh, H. Le, J. Neill, A. Miralles, A. Collins, W. Sandborn, P. Dulai

Created: Thursday, 30 January 2020, 10:12 AM
P302: Cytomegalovirus infection in pediatric acute severe ulcerative colitis – a multicenter case-controlled study from the Pediatric IBD Porto group of ESPGHAN
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cohen S.*1, Martinez-Vinson C.2, Aloi M.3, Turner D.4, Assa A.5, de Ridder L.6, Wolters V.M.7, de Meij T.8, Alvisi P.9, Bronsky J.10, Kopylov U.11

Created: Wednesday, 20 February 2019, 10:36 AM
P302: Faecal calprotectin correlates with small bowel inflammatory activity detected by capsule endoscopy in patients with established Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Barbosa*1, S. Monteiro1, T. Gonçalves1, M. J. Moreira1, B. Rosa1, J. Cotter1, 2, 3

Created: Friday, 22 February 2019, 9:49 AM
P302: Malignancy surveillance in patients with primary sclerosing cholangitis and Inflammatory Bowel Disease – keeping up with international guidelines? A Norwegian cohort study
Year: 2022
Source: ECCO'22
Authors: Tønjum, T.K.(1);Anisdahl, K.(1,2);Folseraas, T.(3);Midgard, H.(2);Høivik, M.L.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P302: Precision medicine for a case with monogenic inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schwärzler, J.P.(1)*;Zollner, A.(1);Dolejsi, T.(2);Enrich, B.(1);Mayr, L.(1);Sturm, W.(1);Tancevski, I.(3);Zschocke, J.(4);Adolph, T.E.(1);Tilg, H.(1);
Created: Friday, 14 July 2023, 11:05 AM
P302: Predictors of outcome in children with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. T. Fioretti*1, C. Strisciuglio2, M. Martinelli1, P. Dolce3, G. Vallone4, A. Staiano1, E. Miele1

Created: Friday, 22 February 2019, 9:41 AM
P302: Pregnant women with ulcerative colitis are more likely than Crohn’s disease to exacerbate during pregnancy
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Bar-Gil Shitrit1*, A. Ben Yaacov2, D.M. Livovsky2, E. Goldin2, B. Koslowsky2

Created: Thursday, 21 February 2019, 9:14 AM
P302: Serum IL-6 is associated with treatment refractoriness in acute severe ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Li Wai Suen, C.(1,2);Morris, R.(3);Choy, M.(1,2);Nigro, J.(3);Visvanathan, K.(3);De Cruz, P.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P303 Role of parietal healing by ultrasound in the evolution of patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Mayor Delgado, C.J. Suarez Ferrer, J. Poza Cordon, E. Martin Arranz, J.L. Rueda Garcia, M. Sanchez Azofra, M. Cuadros Martinez, M.A. Ruiz Ramirez, M.D. Martin Arranz

Created: Thursday, 30 January 2020, 10:12 AM
P303: Biologic Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease: Are we aiming high?
Year: 2022
Source: ECCO'22
Authors: Robertson, A.(1);Hawkins, I.(1);Wilkinson, S.(2);Patel, R.(3);
Created: Friday, 11 February 2022, 3:52 PM
P303: Factors associated with the development of extraintestinal manifestations in patients with ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Yamamoto-Furusho*1, G. Sanchez-Morales2

Created: Friday, 22 February 2019, 9:49 AM
P303: Gastrointestinal infectious agents detected by Biofire FilmArray GI PCR panel stool testing in active inflammatory bowel disease are common and associated with a more benign course of IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Limsrivilai J.1,2, Stidham R.W.3, Govani S.3, Waljee A.3, Gutermuth B.3, Brown A.3, Briggs E.3, Rao K.4, Higgins P.D.*5

Created: Wednesday, 20 February 2019, 10:36 AM
P303: Hyperbilirubinemia can be induced with azathioprin treatment in patients with inflammatory bowel disease: a hospital-based cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Moon*1, K. I. Seo1, S. J. Park1, M. I. Park1, S. U. Lee1, B. C. Yun1, B. H. Han1, E. T. Park1, J. H. Kim1, S. E. Kim1, K. Jung1

Created: Friday, 22 February 2019, 9:41 AM
P303: Local Application of Autologous Platelet-rich Plasma leads to Sustained Healing of Crohn`s Perianal Fistulae – One Year follow-up Results from a Single Center Pilot Study.
Year: 2021
Source: ECCO'21 Virtual
Authors: Podmanicky, D.(1,2);Jezberova, M.(3);Lucenicova, J.(4);Bak, V.(1);Kadleckova, B.(5);Zelinkova, Z.(5);
Created: Wednesday, 2 June 2021, 4:12 PM